What You Should Know: - Glytec recently announced that it has been selected by CPS Solutions, LLC (CPS), a leading provider of enterprise pharmacy solutions to hospitals and health systems, to serve as an insulin management technology resource for CPS’ more than 2,200 pharmacy professionals across 800-plus healthcare facilities nationwide. - Through this collaboration, CPS client facilities may contract for Glytec’s eGlycemic Management System® (eGMS) and Glytec’s technical resources to be
Read More
Personalized Diabetes
Researchers Develop AI Method for Personalized Diabetes Treatment
What You Should Know: - Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized care for diabetes patients needing complex drug treatment. - The new AI method can now be used to help determine an optimal drug regimen for a specific patient. Hitachi, University of Utah Health, and Regenstrief Institute today announced the development of an artificial intelligence (AI) method to improve care for patients with type 2
Read More
Inovalon Launches FHIR-Based Solution for Health Plan Compliance
What You Should Know: - Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act. - The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More
DreaMed Launches Virtual Diabetes Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine
What You Should Know: - As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely. - The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment. - According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More
Lilly to Integrate Dexcom CGMs into Personalized Diabetes Management System
- Eli Lilly has announced a global commercialization agreement to integrate Dexcom’s continuous glucose monitoring (CGM) devices into Lilly’s personalized diabetes management system. - The personalized diabetes management system, currently in development to advance the treatment of diabetes, will integrate connected insulin delivery devices, software and analysis to equip people with diabetes and their healthcare providers with personalized information and guidance to help them better manage
Read More
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Accenture, Roche to Develop Data-Driven Analytics Platform for Diabetes Patients
Accenture is collaborating with Roche to develop a data-driven core analytics platform for Roche’s digital diabetes ecosystem. Under the terms of a five-year agreement, the new platform will be built on the Accenture Intelligent Patient Platform and offered to diabetes patients across North American, Europe and Asia, will allow Roche to gather and analyze data in a secure environment, generate new patient insights, and easily collaborate and integrate with its ecosystem partners and devices. At
Read More
Medtronic, Aetna Form Outcomes-Based Partnership for Diabetic Patients
Medtronic, a medical technology provider has entered into a new outcomes-based, risk-sharing agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management. The agreement will measure health outcomes for a patient with diabetes who transition to Medtronic’s insulin pump therapy that constantly self-adjusts to keep patients’ blood sugar levels in range based on their personalized needs.This outcomes-based, risk-sharing
Read More
Grady Health Goes Live on Glytec’s Personalized Diabetes Therapy Management Platform
Atlanta’s Grady Health System has implemented the Glytec eGlycemic Management System®, a personalized diabetes therapy management solution seamlessly integrated with the Epic EMR. Glytec's eGMS® is currently deployed across all critical care areas -- each assigned an interdisciplinary team of pharmacy, medical and nursing staff to provide localized glycemic governance.Integration with Epic EMReGMS integration with Epic's EMR will allow users direct access from a patient’s chart without the need
Read More
